Cross-sectional study of rheumatoid arthritis treatment in a university hospital.
AUTOR(ES)
Friesen, W T
RESUMO
Drug prescribing patterns for the management of inpatients and outpatients with rheumatoid arthritis (RA) were investigated. The population of patients resembled published epidemiological descriptions of RA patients with respect to age and sex distribution. Multiple drug therapy was common in the treatment of both hospitalised and clinic patients. 90% of all patients with RA received non-steroidal anti-inflammatory drug (NSAID) therapy, indomethacin and naproxen being the two most frequently prescribed NSAIDs for both in- and outpatients. The vast majority of inpatients (85%) and outpatients (79%) received slow-acting antirheumatic drug (SAARD) treatment. 13% of hospitalised patients received H2-antagonist drugs in addition to their NSAIDs. A high proportion of inpatients (46%) received oral corticosteroids in the management of their rheumatoid arthritis, while only 15% of clinic patients were prescribed corticosteroids.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1001655Documentos Relacionados
- Relationship of rheumatoid arthritis and coronary artery disease in the Korean population: a nationwide cross-sectional study
- Audiological Abnormalities in Vitiligo Patients: A Hospital-Based Cross-Sectional Study
- Foot health and quality of life among university students: cross-sectional study
- Depression as a major determinant of PASS (Patient’s Acceptable Symptoms State) in rheumatoid arthritis: a cross-sectional study in Brazilian patients
- Factors associated with mechanical restraint in the hospital environment: a cross-sectional study